Serum Institute CEO Hails WHO’s Approval of Covovax for Emergency Use
Synopsis- India-made Covovax on Friday became the ninth Covid-19 vaccine to receive WHO’s emergency use listing approval, with manufacturer Serum Institute of…
Synopsis- India-made Covovax on Friday became the ninth Covid-19 vaccine to receive WHO’s emergency use listing approval, with manufacturer Serum Institute of…
Summary: The clinical trial results show that the vaccine is safe and effective in this in this age group, it will thus…
Summary : The company also said studies are underway to provide information on the impact of the new Omicron variant on Evusheld,…
Summary : The Pfizer COVID-19 vaccine provides less immunity against Omicron than from other coronavirus variants, according to a lab study that…
Synopsis: The Therapeutic Goods Administration has provisionally approved the Comirnaty (Pfizer) vaccine as safe and effective for use among 5 to 11-year-old…
The European Union-wide rollout of Pfizer and BioNTech’s Covid-19 vaccine version for five- to 11-year-old children will begin Dec 13, one week…
Synopsis : Zydus Cadila’s COVID-19 vaccine ZyCoV-D will be initially introduced in seven States including Bihar, Jharkhand, Maharashtra, Punjab, Tamil Nadu, Uttar…
Drug firm Zydus Cadila on Monday said it has received an order to supply one crore doses of its Covid-19 vaccine, ZyCoV-D,…
SUMMARY: Janssen’s ICEBERG study has demonstrated that Esketamine nasal spray (NS) has shown improved outcomes in an indirect treatment comparison with other…